Sustainable aquaculture as a contribution to food security? Leopoldina webinar on the conditions in Germany and Brazil
Meeting Announcement
Updates every hour. Last Updated: 14-Sep-2025 15:11 ET (14-Sep-2025 19:11 GMT/UTC)
New research shows that treatment of heart failure patients with a type of anti-obesity medication reduces the environmental footprint of healthcare, as well as improving clinical outcomes.
People being treated for heart failure with GLP-1 receptor antagonists used 0.25 kg CO₂-equivalent less per person annually, compared to patients with heart failure taking a placebo. When this saving is scaled to the millions of people eligible for the treatment, the findings suggest that 2 billion kilograms of CO₂-equivalent could be saved annually.
The study is one of the first to quantify the environmental co-benefits of pharmacologic treatment. The authors hope that studies like this will empower policy makers, clinicians and patients to consider environmental outcomes alongside clinical outcomes in the future.
New research warns of declining access to safe, reliable and affordable water in the U.S., urging for better water tracking tools and immediate policy reforms.